Summary
AbbVie Inc. (ABBV) filed an 8-K on November 12, 2020, announcing a significant leadership transition. Carlos Alban, Vice Chairman and Chief Commercial Officer, will retire at the end of the first quarter of 2021, concluding a 34-year career with the company. This departure marks the end of an era for a long-standing executive who has played a key role in AbbVie's commercial operations.
Key Highlights
- 1Carlos Alban, AbbVie's Vice Chairman and Chief Commercial Officer, announced his retirement, effective at the end of Q1 2021.
- 2Mr. Alban has had a 34-year career with the company.
- 3Jeffrey R. Stewart will succeed Mr. Alban as Executive Vice President, Commercial Operations.
- 4Mr. Stewart currently serves as Senior Vice President, U.S. Commercial Operations.
- 5The filing formally announces a planned leadership change in a critical commercial role.